Floatz logo

(±)-TRAMADOL

or Peripheral Nerve Injury (PNI)

Astellas Pharma IncSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the or Peripheral Nerve Injury (PNI) cohort.

Asset / SponsorPhaseRating
Capsaicin
Astellas Pharma Europe Ltd.
Phase 4BBB
Pregabalin
Astellas Pharma Europe Ltd.
Phase 4BB
Rufinamide
University of Zurich
Phase 2CCC

Same molecule, other indications

(±)-TRAMADOL is also rated in:

chronic pain syndromeDormant
BBB
Indicative ·
78 / 100
View asset →
PainDormant
BBB
Indicative ·
72 / 100
View asset →
Neuropathic PainDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →